Genetic variability of incretin receptors affects the occurrence of neurodegenerative diseases and their characteristics

Genetic variability of incretin receptors affects the occurrence of neurodegenerative diseases and their characteristics

Background: Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases. Their treatment options are rather limited, and no neuroprotective or disease-modifying treatments are available. Anti-diabetic drugs, such as glucagon-like peptide 1 (GLP-1) a...

Full description

Saved in:
Bibliographic Details
Main Authors: David Vogrinc, Sara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Heliyon
Subjects:
Glucagon-like peptide 1 receptor
Glucose-dependent insulinotropic polypeptide
Alzheimer's disease
Parkinson's disease
Polymorphism
Biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024151882
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024151882

Similar Items